- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 888 - Related articles - BL Direct - All 21 versions
- ►annals.org [PDF] MC Fang, Y Chang, EM Hylek, J Rosand, SM … - Annals of internal medicine, 2004 - Am Coll Physicians Background: The risk for atrial fibrillation–associated stroke in- creases at
low anticoagulation intensities. However, higher inten- sities increase
hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires ... Cited by 225 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org EM Hylek, C Evans-Molina, C Shea, LE … - Circulation, 2007 - Am Heart Assoc Methods and Results— Consecutive patients who started warfarin were identified
from January 2001 to June 2003 and followed for 1 year. Patients had to be 65
years of age, have established care at the study institution, and have ... Cited by 163 - Related articles - All 6 versions
- ►sinica.edu.tw [PDF] C van Walraven, RG Hart, GA Wells, P … - Archives of Internal Medicine, 2003 - Am Med Assoc Results Overall, 166 patients (6.6%) had an event during 4688.6 person-years
(PYs) of observation for an incident rate of 3.5 events per 100 PYs. Patients in
the derivation set classified as low risk (no previous stroke or transient ... Cited by 130 - Related articles - BL Direct - All 8 versions
- ►chestjournal.org [PDF] C van Walraven, A Jennings, N Oake, D … - Chest, 2006 - chestjournal.chestpubs.org Page 1. DOI 10.1378/chest.129.5.1155 2006;129;1155-1166 Chest Alan J. Forster Carl
van Walraven, Alison Jennings, Natalie Oake, Dean Fergusson and ... Cited by 64 - Related articles - All 7 versions
JD Douketis, PB Berger, AS Dunn, AK Jaffer, … - Chest, 2008 - chestjournal.chestpubs.org This article discusses the perioperative management of antithrombotic therapy
and is part of the American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines (8th Edition). The primary objectives of this article ... Cited by 64 - Related articles - BL Direct - All 16 versions
D Garcia, S Regan, M Crowther, RA Hughes, … - Chest, 2005 - chestjournal.chestpubs.org * From the Department of Medicine (Dr. Garcia), Division of General Internal
Medicine, University of New Mexico School of Medicine, Albuquerque, NM; the
Department of Medicine (Drs. Regan and Hughes), General Medicine Division, ... Cited by 55 - Related articles - All 7 versions
AK Hamberg, ML Dahl, M Barban, MG Scordo, … - Clinical Pharmacology & Therapeutics, 2007 - nature.com The aim of this study was to characterize the relationship between warfarin
concentrations and international normalized ratio (INR) response and to identify
predictors important for dose individualization. S- and R-warfarin ... Cited by 34 - Related articles - All 4 versions
- ►muhealth.org [PDF] KJ DeZee, WT Shimeall, KM Douglas, NM … - Archives of Internal Medicine, 2006 - archinte.highwire.org Methods The MEDLINE, EMBASE, and Cochrane Library databases were searched
(without language restrictions) for articles published between January 1985 and
September 2004. Randomized controlled trials or prospective, nonrandomized ... Cited by 27 - Related articles - BL Direct - All 5 versions
EM Hylek - Seminars in Vascular Medicine, 2003 - thieme-connect.com Oral anticoagulant therapy is very effective in preventing thromboembolism. Its
major complication is hemorrhage. The rate of intracranial bleeding from
randomized trials and observational studies ranges from 0.1 to 0.9% per ... Cited by 20 - Related articles - BL Direct - All 6 versions
